Cliff Asness’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-24,070
Closed -$3.28M 2304
2020
Q3
$3.28M Buy
24,070
+9,429
+64% +$1M 0.01% 901
2020
Q2
$1.42M Buy
14,641
+6,339
+76% +$529K ﹤0.01% 1315
2020
Q1
$389K Buy
+8,302
New +$532K ﹤0.01% 1669
2019
Q2
Sell
-6,736
Closed -$350K 2236
2019
Q1
$350K Sell
6,736
-8,272
-55% -$381K ﹤0.01% 1921
2018
Q4
$733K Sell
15,008
-6,479
-30% -$357K ﹤0.01% 1624
2018
Q3
$1.4M Sell
21,487
-19,946
-48% -$1.17M ﹤0.01% 1556
2018
Q2
$2.06M Sell
41,433
-44,608
-52% -$2.16M ﹤0.01% 1411
2018
Q1
$4.2M Sell
86,041
-8,324
-9% -$433K ﹤0.01% 1063
2017
Q4
$3.97M Buy
94,365
+83,535
+771% +$3.22M ﹤0.01% 1117
2017
Q3
$464K Buy
+10,830
New +$346K ﹤0.01% 1968

Cliff Asness's MYOK Position: Q4 2020 in Review

Cliff Asness sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 24,070 shares — an estimated $3.28M sold.

Cliff Asness first reported a position in MYOK in Q3 2017 and held it in 10 quarters. The position peaked at $4.2M in Q1 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Cliff Asness reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Cliff Asness sold 24,070 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3.28M.
  • Cliff Asness first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 10 quarters.
  • Cliff Asness's MyoKardia, Inc. Common Stock position peaked at $4.2M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.